Skip to content
Sotera Health logo

Sotera Health

SHC

Sotera Health is a leading global provider of mission-critical sterilization, lab testing, and advisory services for the healthcare industry.

Market cap
$4.96B+47.5%
Revenue$1.2B+7.4%
Net income$117.8M+375%
Free cash flow$96.8M+58.0%
EPS (diluted)$0.41+356%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$309.7M
EPS estimate$0.24

Financials

Q1 2026

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation & ratios

Valuation

See full
Market cap$4.96B+47.5%
Enterprise value$6.92B+32.0%
P/E42.1×-92.1×
P/S4.2×+1.3×

Profitability

See full
Gross margin55.3%+0.1pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Segments

By segment

See full
Sterigenics$186.1M+9.7%
Nelson Labs$51.9M-0.7%
Nordion$42.0M+29.0%

By product

See full
Service$241.6M+7.9%

Competitors

Profile

Sotera Health is a leading global provider of mission-critical sterilization, lab testing, and advisory services for the healthcare industry. The company offers end-to-end solutions to ensure the safety of medical devices, pharmaceutical products, and food supplies across the global supply chain. Its value proposition centers on safeguarding global health by helping customers meet stringent regulatory requirements and ensuring products are safe for healthcare practitioners and patients.

Competitive position

A dominant global player in the highly regulated sterilization and lab testing market, characterized by high barriers to entry due to capital intensity and regulatory expertise.

GeographiesUnited States, Canada, United Kingdom, Belgium, Germany, Global
Customer segmentsMedical Device Companies, Pharmaceutical Companies, Food & Beverage Companies
Business modelB2B Service, Contract Manufacturing & Services, Specialized Logistics
SuppliersNuclear reactor operators, Nickel and copper mining (for Co-59), Ethylene Oxide suppliers, Laboratory supply vendors
CustomersHospitals and healthcare practitioners, Surgical centers, Retail pharmacies, Food distributors
Listed2020
Employees3.0K
CEOAlton E. Shader
FilingsSEC EDGAR

Questions, answered.

What is Sotera Health's market cap?
Sotera Health (SHC) has a market capitalization of $4.9B and trades on NASDAQ.
What is Sotera Health's revenue and profitability?
Sotera Health generated $1.2B in trailing twelve-month revenue with net income of $117.8M, representing a net margin of 9.9%. Gross margin stands at 55.3%, with free cash flow of $96.8M. These figures are based on the Q1 2026 filing.
Who are Sotera Health's competitors?
Sotera Health's key competitors include STERIS plc, Charles River Laboratories, American Shared Hospital Services, and others. These companies compete in similar markets and product categories.
Who does Sotera Health partner with?
Sotera Health's notable partners include Westinghouse Electric Company, PSEG, Elekta.
What subsidiaries does Sotera Health have?
Sotera Health's subsidiaries include Sterigenics, Nordion, Nelson Labs, and others.
Where is Sotera Health headquartered?
Sotera Health is headquartered in United States of America and employs approximately 3,000 people. It has been publicly traded since 2020.